v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (18,834) $ (25,016)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 2,692 3,224
Depreciation and amortization expense 827 835
Noncash lease expense 1,449 1,419
Accretion of discount on marketable securities (818) (554)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 1,069 1,328
Accounts payable 284 (629)
Accrued expenses and other liabilities (2,407) (2,808)
Operating lease liabilities (2,279) (2,094)
Deferred revenue (5,951) (5,050)
Net cash used in operating activities (23,968) (29,345)
Cash flows from investing activities:    
Purchases of property and equipment (28) (101)
Purchases of marketable securities (51,124) (31,263)
Proceeds from maturities of marketable securities 80,553 58,459
Net cash provided by investing activities 29,401 27,095
Cash flows from financing activities:    
Proceeds from issuance of common stock upon exercise of stock options and employee stock purchase plan 139 1,167
Net cash provided by financing activities 139 1,167
Net increase (decrease) in cash, cash equivalents and restricted cash 5,572 (1,083)
Cash, cash equivalents and restricted cash at beginning of period 57,162 82,044
Cash, cash equivalents and restricted cash at end of period 62,734 80,961
Supplemental disclosure and noncash investing and financing information:    
Cash paid for taxes 4 49
Asset acquired in finance lease 1,208 0
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 61,026 79,253
Restricted cash 1,708 1,708
Total cash, cash equivalents and restricted cash shown in the statement of cash flows $ 62,734 $ 80,961